Crossix Announces Next Release of its DIFA™ Digital Measurement Platform
Recent enhancements to Crossix DIFA™ provide an unparalleled breadth, depth, and granularity of campaign insights for healthcare agencies and brands
NEW YORK, NY – February 2, 2017 – Crossix Solutions, a leader in consumer-centric healthcare analytics, has announced major enhancements to its market-leading digital advertising measurement platform, Crossix DIFA™, which has been used to optimize more than 100 campaigns to date. The preferred platform used by agencies and brands to optimize over 10 billion display, video, and mobile media impressions, DIFA enables health advertisers to measure the audience, impact and incremental sales and ROI of their digital efforts. The cloud-based DIFA provides unrivaled granularity of data and insights through its control-based methodology, providing not just overall campaign results, but also performance by publisher.
In response to client demand, and on the heels of Crossix’s largest-ever expansion of connected health data, Crossix has completed a series of key DIFA enhancements, including:
- Expanded clinical data sets including diagnosis, lab results, and electronic health records (EHR) for a more complete view of the patient journey, in addition to category and brand treatment data
- Placement-level optimization to drive ongoing optimization decisions by specific ad placement
- Additional demographic data for both individuals and households
- Geo data now available at a state level
- Website & search analyses provide best-in-class measurement of brand websites (DIFA Site™) and search campaigns (DIFA Search™) for a more holistic, cross-channel view of digital performance
“Our clients already depend on the insights that DIFA provides. But now with these expanded metrics, we can unlock brand new campaign insights and really dig into a campaign to assess which elements are performing best and optimize accordingly.”
- Jacob Lustig, VP, Media Innovations at Klick Health
Other recent DIFA enhancements include the addition of cookie and mobile/device based tracking, making it one of the only at-scale solutions to combine cookie, device and panel data to identify the audiences exposed to digital campaigns. DIFA also now includes stability scores, which instill greater confidence in the statistical significance of results and help marketers determine the actionability of the data.
“The feedback we’ve received from DIFA clients about these recent enhancements has been overwhelmingly positive,” said Dan Stein, SVP of product strategy at Crossix. “It’s great to see so many clients developing support models and utilizing the DIFA platform as an integral part of their marketing process. DIFA is uniquely positioned to meet their needs.”
To learn more about Crossix DIFA, visit www.crossix.com/DIFA or contact us.
About Crossix Solutions
Crossix partners with leading healthcare and media companies to plan, measure and optimize their marketing and communication initiatives. With deep consumer and healthcare professional expertise, Crossix delivers hard-to-come-by audience and campaign insights to inform strategic business decisions and drive improved patient outcomes. Data-driven and data-proven, the patented Crossix methodology and differentiated technology enable critical connections across its proprietary data network of Rx, OTC, medical, clinical, media and consumer data to ensure more actionable cross-channel measurement with best-in-class privacy safeguards far exceeding HIPAA requirements. The unique Crossix technology aggregates insights from across the data network to pinpoint marketing initiatives that activate the right audiences and generate incremental impact. Founded in 2004, Crossix is headquartered in New York City. Follow Crossix on Twitter at @Crossix.